Suitability of the woodchuck HCC as a preclinical model for evaluation of intra‐arterial therapies
Abstract The most commonly used preclinical models of hepatocellular carcinoma (HCC) are limited for use in testing of intra‐arterial therapies such as transarterial chemoembolization and radioembolization. Issues encountered with the more commonly used animal models include dissimilarity in their d...
Main Authors: | Alexander Y. Kim, Joseph H. Yacoub, David H. Field, Byoung Uk Park, Bhaskar Kallakury, Kyle E. Korolowicz, Stephan Menne |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Animal Models and Experimental Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ame2.12100 |
Similar Items
-
Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B
by: Kyle E. Korolowicz, et al.
Published: (2021-04-01) -
The Genome Sequence of the Eastern Woodchuck (Marmota monax) – A Preclinical Animal Model for Chronic Hepatitis B
by: Tyler S. Alioto, et al.
Published: (2019-12-01) -
Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects
by: Manasa Suresh, et al.
Published: (2021-10-01) -
Magnetic resonance characterization of hepatocellular carcinoma in the woodchuck model of chronic viral hepatitis
by: McKenzie, Eilean J
Published: (2009) -
Magnetic resonance characterization of hepatocellular carcinoma in the woodchuck model of chronic viral hepatitis
by: McKenzie, Eilean J
Published: (2009)